Majority of stock indexes are falling now despite healthcare, rubber, textile, and paper manufacturing companies’ share prices are soaring. Inovio Pharmaceuticals is one of the major players in fighting the COVID-19. The company focuses on cancer and infectious diseases that normally could allocate resources in creating a vaccine against the ruthless novel coronavirus.
From March 5 to 9 the stock price increased from $9.78 to $17.143. Such a huge rocketing price could surely get the impact of the COVID-19. The average volume 27,496,946 which is less than the total volume 34,746,419.
Throughout several years there has been an only net loss. However, the company operates due to investors’ funding. Obviously, investors have the motivation to fight cancer and infectious diseases.